HZ/su vaccine GSK1437173A
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HZ/su vaccine GSK1437173A, covering 2017-01-06 to 2018-10-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age [Phase 3]